Jialing Wu

Jialing Wu

Auto-generated profile, based on publicly available information

Jialing Wu

Rheumatology and Immunology Department, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
ZCZena Chen
Zena Chen
XZXuqi Zheng
Xuqi Zheng
XWXinyu Wu
Xinyu Wu
JWJialing Wu
Jialing Wu
XLXiaomin Li
Xiaomin Li
JGJieruo Gu
Jieruo Gu
Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarkers predicting treatment response. By evaluating the gut microbial features of 30 AS patients before and after adalimumab therapy for 6 months and 24 healthy controls, we confirmed that the microbiome was restored remarkably after 6 months of adalimumab therapy in AS patients. We then compared the baseline gut microbiome of 22 adalimumab responders with 8 non-responders, a higher abundance of Comamonas was revealed in the latter, although no statistical difference was found after adjusting for the false discovery rate. These results suggested that adalimumab therapy restored the gut microbiome in AS patients and indicated the utility of gut microbiome to be potential biomarkers for therapeutic evaluation. These findings provided an insight into the development of predictive tools and the establishment of precise medical interventions for clinical practice.

1 September 2017 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
Yi-Ming ChenYi-Ming Chen
Yi-Ming Chen
JWJiaLing Wu
JiaLing Wu
SGSandhya Gokavarapu
Sandhya Gokavarapu
QSQingcheng Shen
Qingcheng Shen
TJTong Ji
Tong Ji
The vascular fibula flap is an ideal choice for function and appearance reconstruction of mandible. Despite the high success rate, “late complications” such as Ti plate exposure and local infection related to osteosynthesis are not uncommon. A retrospective cohort of patients who received vascular fibula reconstruction for mandible from January 2011 to December 2013 from the Department of Oral and Maxillofacial Oncology in a tertiary hospital were charted: clinical, pathological, and therapeutic factors were analyzed for late complications in univariate and multivariate analyses. One hundred forty-two patients were finally analyzed with median follow-up time of 47 months; 19 of them had “late complications,” which occurred at a median of 8 months. Preoperative or postoperative radiotherapy (P = 0.02), type of Ti plate (P = 0.019), and the disease characteristics (P = 0.02) were significant factors on univariate. Cox regression suggested postoperative radiation (P = 0.009) and smoking history (P = 0.037) were independent significant factors for late complications. Secondary reconstruction (P = 0.069) and preoperative radiotherapy (P = 0.086) were borderline significant. Postoperative radiation and smoking history are associated with late complications. Mini Ti plate should be less used. Patients with risk factors need to be observed for at least 6 to 16 months before further management.

14 November 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
LZLuodan Zhao
Luodan Zhao
YYYushan Ye
Yushan Ye
JJJiuyang Jiao
Jiuyang Jiao
JLJunkun Liao
Junkun Liao
ZLZhaoyu Lin
Zhaoyu Lin
SFSong Fan
Song Fan

1 January 2021 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
JWJialing Wu
Jialing Wu
KYKaiyun You
Kaiyun You
XQXingsheng Qiu
Xingsheng Qiu
TSTing Shen
Ting Shen
JSJuanjuan Song
Juanjuan Song
YLYimin Liu
Yimin Liu
Purpose: Local failure after endoscopic laryngeal surgery (ELS) for early glottic cancer mounts a challenge to researchers to investigate risk factors of recurrence. The present study was therefore designed to explore the prognostic factors in patients who underwent ELS for early glottic cancer. Patients and Methods: We reviewed 328 patients with T1-2N0 glottic cancer who were treated with either ELS or open surgery between 2007 and 2018 at our institution. Survival, univariate and multivariate analyses were performed in different groups (ELS vs open surgery; < 65 vs > 65 years). Results: Age was discovered to be the independent prognostic factor of DFS for patients treated with ELS (HR = 3.673, p = 0.003), but not for patients who underwent open surgery. Survival analysis performed on young patients (< 65 years) showed that survival outcomes between different surgery modalities were significantly different (ELS vs open surgery: fiveyear DFS: 72.5 vs 84.7%, p = 0.034). Univariate and multivariate analyses further confirmed the finding, whereas these results did not appear in old patients (> 65 years). Conclusion: Young patients (< 65 years) treated with ELS had less favorable oncologic outcomes than those treated with open surgery. Young patients (< 65 years) are advised to consider open surgery over ELS.